Roemer Alan S.
- SEC CIK
- 0001643070
No open-market purchases or sales filed in the past year.
Current role at each company
- INAB IN8BIO, Inc.Directoras of Dec 23, 2025
- NEXI NexImmune, Inc.Directoras of Nov 22, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Roemer Alan S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NEXI NexImmune, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 (view filing) | Nov 21-22 | 1 day | Roemer Alan S.Director | SSale | −7.83K | $2.05 | −$16.0K | −100.0%0 after | 2 lots |
INAB IN8BIO, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Roemer Alan S.Director | PPurchase | +26.3K | $1.90 | +$50.0K | +88.7%56.0K after |